Table 1 Patient characteristics
|  | IMRT without replanning (N = 100), n (%) | IMRT with replanning (N = 174), n (%) | P |
|---|---|---|---|
Sex | Â | Â | 0.524 |
 Male | 67 (67.0) | 123 (70.7) |  |
 Female | 33 (33.0) | 51 (29.3) |  |
 Median age (IQR), years | 55 (49–65) | 56(47–65) | 0.776 |
Smoking | Â | Â | 0.317 |
 Yes | 40 (40.0) | 80 (46.2) |  |
 No | 60 (60.0) | 93 (53.8) |  |
T stage | Â | Â | 0.782 |
 1 | 23 (23.0) | 39 (22.4) |  |
 2 | 34 (34.0) | 50 (28.7) |  |
 3 | 24 (24.0) | 46 (26.4) |  |
 4 | 19 (19.0) | 39 (22.4) |  |
N stage | Â | Â | 0.752 |
 0 | 19 (19.0) | 29 (16.7) |  |
 1 | 22 (22.0) | 47 (27.0) |  |
 2 | 52 (52.0) | 89 (51.1) |  |
 3 | 7 (7.0) | 9 (5.2) |  |
Clinical stage | Â | Â | 0.998 |
 I | 5 (5.0) | 9 (5.2) |  |
 II | 20 (20.0) | 34 (19.5) |  |
 III | 50 (50.0) | 86 (49.4) |  |
 IVa | 25 (25.0) | 45 (25.9) |  |
Chemotherapy | Â | Â | 0.934 |
 AC | 86 (86.0) | 147 (84.5) |  |
 IC | 9 (9.0) | 18 (10.3) |  |
 No | 5 (5.0) | 9 (5.2) |  |